WSFG
GILD icon

Wall Street Financial Group’s Gilead Sciences GILD Stock Holding History

Wall Street Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Buy
2,552
+379
+17% +$49.9K 0.17% 85
2026
Q1 		$303K Sell
2,173
-447
-17% -$62.6K 0.18% 78
2025
Q4 		$322K Buy
2,620
+187
+8% +$22.7K 0.23% 64
2025
Q3 		$270K Buy
2,433
+620
+34% +$70.5K 0.2% 74
2025
Q2 		$201K Buy
+1,813
New +$193K 0.18% 78

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Wall Street Financial Group's GILD Position: Q2 2026 in Review

Wall Street Financial Group increased its Gilead Sciences (GILD) stake by 17% in Q2 2026, buying an estimated $49.9K and bringing the position to 2,552 shares worth $322K. The position accounts for 0.17% of the portfolio, ranked #85.

Wall Street Financial Group first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. 920 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wall Street Financial Group held 2,552 shares of Gilead Sciences worth $322K as of Q2 2026.
  • Wall Street Financial Group bought 379 Gilead Sciences shares in Q2 2026, an estimated $49.9K.
  • Gilead Sciences made up 0.17% of Wall Street Financial Group's portfolio in Q2 2026, its #85 holding.
  • Wall Street Financial Group first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • 920 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.